source
- RegCell secures multi-million dollar Series A to advance Nobel-winning regulatory T-cell therapyRegCell, a biotech founded by Nobel laureate Shimon Sakaguchi, announced a new financing round to move its regulatory T-cell (Treg) program toward clinical testing. The company’s CEO Michael McCul…
- Medicare AI prior-authorization pilot plagued by rollout glitches, causing care delaysDocuments obtained through a Freedom of Information Act lawsuit reveal that the Medicare program using artificial intelligence for prior authorization was launched hastily and suffered numerous tec…